Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.54 USD | -3.84% | -2.42% | -22.94% |
Strengths
- The company appears to be poorly valued given its net asset value.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- With a 2024 P/E ratio at 25.28 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.87% | 3.31B | B- | ||
-4.91% | 182B | C+ | ||
+0.46% | 110B | C | ||
-3.62% | 67.92B | A | ||
+3.26% | 50.96B | B- | ||
+9.11% | 44.7B | B- | ||
+2.70% | 40.66B | B+ | ||
+6.39% | 27.6B | B | ||
+3.83% | 26.63B | A- | ||
-0.21% | 24.98B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NVST Stock
- Ratings Envista Holdings Corporation